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Malic enzyme catalyzes the reversible oxidative decarboxylation of malate to pyruvate and CO2. The
Saccharomyces cerevisiae MAE1 gene encodes a mitochondrial malic enzyme whose proposed physiological roles
are related to the oxidative, malate-decarboxylating reaction. Hitherto, the inability of pyruvate carboxylase-
negative (Pyc) S. cerevisiae strains to grow on glucose suggested that Mae1p cannot act as a pyruvate-
carboxylating, anaplerotic enzyme. In this study, relocation of malic enzyme to the cytosol and creation of
thermodynamically favorable conditions for pyruvate carboxylation by metabolic engineering, process design,
and adaptive evolution, enabled malic enzyme to act as the sole anaplerotic enzyme in S. cerevisiae. The
Escherichia coli NADH-dependent sfcA malic enzyme was expressed in a Pyc S. cerevisiae background. When
PDC2, a transcriptional regulator of pyruvate decarboxylase genes, was deleted to increase intracellular
pyruvate levels and cells were grown under a CO2 atmosphere to favor carboxylation, adaptive evolution
yielded a strain that grew on glucose (specific growth rate, 0.06  0.01 h1). Growth of the evolved strain was
enabled by a single point mutation (Asp336Gly) that switched the cofactor preference of E. coli malic enzyme
from NADH to NADPH. Consistently, cytosolic relocalization of the native Mae1p, which can use both NADH
and NADPH, in a pyc1,2 pdc2 strain grown under a CO2 atmosphere, also enabled slow-growth on glucose.
Although growth rates of these strains are still low, the higher ATP efficiency of carboxylation via malic enzyme,
compared to the pyruvate carboxylase pathway, may contribute to metabolic engineering of S. cerevisiae for
anaerobic, high-yield C4-dicarboxylic acid production.
Malic enzyme is a ubiquitous enzyme that catalyzes the re-
versible oxidative decarboxylation of malate to pyruvate and
CO2, using either NAD
 (EC 1.1.1.38-39) or NADP (EC
1.1.1.40) as the redox cofactor. In eukaryotes, malic enzyme
has been found in the cytosol and/or in mitochondria and, in
plants, in the chloroplasts (20, 35). The reaction has a G0 of
ca. 8 kJ mol1 in the decarboxylating direction (19) and,
although both carboxylation and decarboxylation have been
observed in vitro, substrate affinities and maximum reaction
rates generally appear to favor the latter (5, 14, 34). Despite
decades of study, the physiological function of malic enzyme
often remains enigmatic. Proposed physiological roles for the
decarboxylating reaction include provision of pyruvate, inor-
ganic carbon, reducing power, and pH regulation (20, 26).
Carboxylating roles for malic enzyme have also been suggested
(25, 30), although in vivo evidence is sparse. The strongest
indications for in vivo malic enzyme activity in the carboxylat-
ing direction come from experiments with engineered Esche-
richia coli, in which overexpression of malic enzyme improved
succinate titers (17, 27, 28). However, interpretation of these
results was complicated by the fact that these strains still ex-
pressed phospho-enol-pyruvate carboxylase, the main carbox-
ylating enzyme in glucose-grown wild-type E. coli (2).
In the yeast Saccharomyces cerevisiae, malic enzyme is en-
coded by the MAE1 gene (4). The mitochondrial Mae1 protein
can use both NAD and NADP as an electron acceptor and
exhibits a relatively high Km toward malate (50 mM, or 17 mM
in the presence of 0.5 mM phospho-enol-pyruvate [PEP]) (13).
Also in S. cerevisiae, the physiological role of malic enzyme is
still uncertain even though the enzyme has been shown to
provide the pyruvate required for biosynthesis in pyruvate ki-
nase-negative strains grown on ethanol (4). No kinetic data
have been published for the carboxylating reaction, but the
inability of pyruvate carboxylase-negative strains of S. cerevisiae to
grow on glucose indicates that Mae1p cannot readily take over
the anaplerotic role of pyruvate carboxylase (29). Consequently,
the in vivo reaction catalyzed by Mae1p is often assumed to be
irreversible in the decarboxylating direction (23).
In recent years, interest in the biotechnological production
of C4-dicarboxylic acids has intensified, as these acids are en-
visaged to become key building blocks in an increasingly “bio-
based” chemical industry (24, 36). S. cerevisiae is an interesting
production host for organic acids (1). Hitherto, attempts to
engineer S. cerevisiae for malate (and succinate) production
were based on replacement of the native alcoholic fermenta-
tion pathway by a malate fermentation pathway. To this end,
pyruvate carboxylase, a cytosolically retargeted malate dehy-
drogenase and a heterologous malate transporter were (over)
expressed in a pyruvate decarboxylase-negative strain (38, 39).
Although this approach yielded malate titers of up to 59 g
liter1, ATP hydrolysis by pyruvate carboxylase precludes a net
synthesis of ATP via this fermentative pathway. In practice,
ATP yields are even expected to be negative due to energy
requirements for dicarboxylic acid export (32). As a result, part
of the glucose fed to the cultures has to be respired to provide
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ATP, which goes at the expense of the product yield on glu-
cose. Improved understanding of the energetics and thermo-
dynamics of C3-C4 carboxylation reactions is therefore not only
of fundamental physiological interest but may also have indus-
trial applications.
In the last step of glycolysis, pyruvate kinase transfers the
phosphate group of PEP to ADP, producing pyruvate and
ATP. In wild-type S. cerevisiae strains grown on glucose,
anaplerosis occurs via pyruvate carboxylase, which converts
pyruvate to oxaloacetate and consumes 1 ATP per carbox-
ylation. As a result, the overall conversion of PEP to oxa-
loacetate is ATP neutral. However, if pyruvate kinase can be
combined with malic enzyme, which converts pyruvate to
malate without consuming ATP, PEP is converted to malate
while producing net ATP. The same gain in ATP yield can
be achieved by using phospho-enol-pyruvate carboxykinase
(PEPCK), which converts PEP directly to oxaloacetate while
producing ATP. Any reaction with an improved ATP yield has
a lower thermodynamic driving force, since phosphorylation of
ADP requires an input of free energy. That this can impose
limits on metabolism is illustrated by a previous study, where
PEPCK was shown to be able to function as an anaplerotic
enzyme in S. cerevisiae, but only when concentrations of the
substrates PEP and CO2 were increased (40).
The goal of the present study was to investigate the require-
ments for an in vivo carboxylating role of malic enzyme in a
pyruvate carboxylase-negative S. cerevisiae strain grown on glu-
cose as the sole carbon source. Since in S. cerevisiae endoge-
nous malic enzyme (Mae1p) is mitochondrial, while the pyru-
vate carboxylases (Pyc1p and Pyc2p) are cytosolic, various
malic enzyme expression constructs were tested: (i) overex-
pression of the endogenous Mae1p, (ii) expression of a trun-
cated form of Mae1p without the mitochondrial targeting se-
quence, and (iii) expression of the NADH-dependent malic
enzyme from E. coli. In addition, the impact of the substrate
concentrations of the malic enzyme reaction was tested by
varying CO2 concentrations and decreasing the activity of a
pyruvate consuming reaction.
MATERIALS AND METHODS
Strains and maintenance. Strains constructed in the present study (Table 1)
were derived from IMK157, an S. cerevisiae strain derived from the CEN.PK
family (31), containing targeted deletions of URA3 and the two pyruvate car-
boxylase genes PYC1 and PYC2 (40). Exceptions were strains IMY030 to
IMY032, which originate from S. cerevisiae BY4741 mae1 (37). Strains were
maintained on YPD (demineralized water; yeast extract [BD Difco], 10 g liter1;
peptone [BD Difco], 20 g liter1; glucose, 20 g liter1) or, for strains carrying
plasmids, on synthetic stock medium (demineralized water; KH2PO4, 3 g liter1;
MgSO4, 0.5 g liter1; L-aspartic acid [from a filter-sterilized 7.4-g liter1 solution
set to pH 6 with KOH], 6.6 g liter1; K2SO4, 6.6 g liter1; glucose, 20 g liter1;
trace elements and filter-sterilized vitamins) (33). Culture stocks, prepared from
shake flask cultures by the addition of glycerol (20% [vol/vol]), were stored at
80°C in 1-ml aliquots. Incubations were performed at 30°C, and shake flasks
were kept in orbital shakers at 200 rpm.
Plasmid construction and transformation. Plasmid pUG-hphNT1 (Table 2)
was constructed by replacing the kanMX marker in pUG6 (15) with the hphNT1
TABLE 1. S. cerevisiae strains used in this study
Strain Genotype
CEN.PK 113-7D...................................................MATa, reference strain
IMK157 ura3......................................................MATa pyc1::kanMx pyc2::ILV2smr ura3-52
IMK299 .................................................................MATa pyc1::kanMx pyc2::ILV2smr pdc2::loxP::hph::loxP ura3-52
IMW012 ................................................................MATa pyc1::kanMx pyc2::ILV2smr pdc2::loxP::hph::loxP ura3-52 (cured); derived from IMY017
IMY007 empty vector .........................................MATa pyc1::kanMx pyc2::ILV2smr ura3-52 (pUDC1)
IMY016 .................................................................MATa pyc1::kanMx pyc2::ILV2smr pdc2::loxP::hph::loxP ura3-52 (MB5573)
IMY017 .................................................................MATa pyc1::kanMx pyc2::ILV2smr pdc2::loxP::hph::loxP ura3-52 (MB5573*); evolved
IMY019 .................................................................MATa pyc1::kanMx pyc2::ILV2smr ura3-52 (MB5573)
IMY024 .................................................................MATa pyc1::kanMx pyc2::ILV2smr pdc2::loxP::hph::loxP ura3-52 (MB5573*)
IMY025 .................................................................MATa pyc1::kanMx pyc2::ILV2smr ura3-52 (pUDC10)
IMY026 .................................................................MATa pyc1::kanMx pyc2::ILV2smr ura3-52 (pUDC9)
IMY027 .................................................................MATa pyc1::kanMx pyc2::ILV2smr pdc2::loxP::hph::loxP ura3-52 (pUDC10)
IMY028 .................................................................MATa pyc1::kanMx pyc2::ILV2smr pdc2::loxP::hph::loxP ura3-52 (pUDC9)
IMY029 .................................................................MATa pyc1::kanMx pyc2::ILV2smr pdc2::loxP::hph::loxP ura3-52 (pUDC9); derived from IMY017
BY4741 mae1.....................................................MATa his31 leu20 met150 ura30 mae1::kanMX
IMY030 .................................................................MATa his31 leu20 met150 ura30 mae1::kanMX (pUDC1)
IMY031 .................................................................MATa his31 leu20 met150 ura30 mae1::kanMX (MB5573)
IMY032 .................................................................MATa his31 leu20 met150 ura30 mae1::kanMX (MB5573*)
TABLE 2. Plasmids used in this study
Plasmid Characteristics Reference
pFA6a-hphNT1 Template for hphNT1 18
pUG6 Template for loxP-kanMX-loxP deletion cassette 15
pUG-hphNT1 Template for loxP-hphNT1-loxP deletion cassette This study
p416-GPD Centromeric yeast vector, URA3, PTDH3-TCYC1 22
MB5573 Centromeric yeast vector, URA3, PTDH3-E. coli sfcA-TCYC1 This study
MB5573* Centromeric yeast vector, URA3, PTDH3-E. coli sfcA-TCYC1, isolated from strain IMY017 This study
pUDC1 Centromeric yeast vector, URA3, PTDH3-TCYC1 40
pUDC9 Centromeric yeast vector, URA3, PTDH3-sMAE1-TCYC1 This study
pUDC10 Centromeric yeast vector, URA3, PTDH3-MAE1-TCYC1 This study
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marker (conferring hygromycin B resistance) from pFA6a-hphNT1 (18) using
the SacI and BglII restriction sites. The PDC2 deletion cassette was prepared
by PCR using pUG-hphNT1 with primers 5-PDC2-S1 and 3-PDC2-S2 (Ta-
ble 3) (10). Transformants of strain IMK157 were selected on YP agar
containing ethanol (3% [vol/vol]), glycerol (2% [vol/vol]), and hygromycin B
(200 mg liter1). A single colony isolate, for which deletion of PDC2 was
confirmed by PCR, was named IMK299.
A synthetic gene, consisting of E. coli sfcA malic enzyme (also known as maeA)
with flanking SpeI and XhoI restriction sites, was inserted into p416-GPD (22)
digested with XbaI and XhoI (synthesis and codon optimization for expression in
S. cerevisiae were performed by Blue Heron Biotechnology, Bothell, WA). The
resulting plasmid was named MB5573 (Table 2). S. cerevisiae MAE1 and the
truncated version sMAE1 (21) were amplified from CEN.PK 113-7D genomic
DNA with primers 5-MAE1-XbaI or 5-sMAE1-XbaI and 3-MAE1-SalI (Table
3). After digestion with XbaI and SalI, the PCR products were inserted into
p416-GPD via the XbaI and XhoI sites, resulting in plasmids pUDC9 (expressing
sMAE1) and pUDC10 (expressing MAE1) (Table 2). Correct PCR amplification
was verified by sequencing, performed by BaseClear, Netherlands.
Yeast transformations were performed as described previously (7). Transfor-
mants were selected on synthetic glucose medium agar plates without uracil and
with aspartate as the nitrogen source. Histidine (25 mg liter1), leucine (30 mg
liter1), and methionine (25 mg liter1) were added as required. Transforma-
tions were verified by PCR.
Plate cultivation. Solid media were prepared by addition of 20 g of Bacto agar
liter1. Apart from the nitrogen source [either 4 g of aspartate or 2 g of
(NH4)2SO4 liter1] and the addition of Tween 80 (0.42 g liter1) and ethanol-
dissolved ergosterol (10 mg liter1), added to allow for growth under anaerobic
conditions, solid synthetic media were identical to the synthetic stock culture
medium. Gas-tight jars with 0.2 bar of overpressure were used for incubation of
agar plates under CO2 atmosphere.
Batch cultivation. Batch cultivation was performed at 30°C in 2-liter bioreac-
tors (Applikon, Schiedam, Netherlands) at a working volume of 1 liter. The pH
was controlled by automatic addition of 2 M KOH. Bioreactors were sparged
with 250 ml of CO2 per min and stirred at 800 rpm. The medium was identical
to the synthetic stock culture medium, except for the replacement of the aspartic
acid and K2SO4 by 5 g of (NH4)2SO4 liter1 and the addition of 0.15 ml of silicon
antifoam (BDH, Poole, England) liter1 to control foaming. Tween 80 (0.42 g
liter1) and ethanol-dissolved ergosterol (10 mg liter1) were added to the
medium to allow for growth under anaerobic conditions. For growth rate mea-
surements, the initial optical density at 660 nm (OD660) after inoculation was
0.1. Maximum specific growth rates were determined for duplicate cultures
(errors are given as deviations from the mean) and based on the OD660. Precul-
ture shake flasks with synthetic stock medium were inoculated with 1-ml aliquots
of frozen stock culture. Cells from exponentially growing shake-flask precultures
were washed twice with demineralized water and used to inoculate batch cul-
tures.
Selection of IMY017. Nitrogen-limited medium for the selection of strain
IMY017 was based on the synthetic stock culture medium, with the following
modifications: medium contained 1 g of (NH4)2SO4 and 5.3 g of K2SO4 liter1,
as well as 30 g of glucose liter1, 0.15-ml liter1 of silicon antifoam (BDH, Poole,
England) to control foaming, Tween 80 (0.42 g liter1), and ethanol-dissolved
ergosterol (10 mg liter1) to allow for growth under anaerobic conditions. Me-
dium was added via a peristaltic pump, and the working volume was kept
constant by means of a conductive level sensor.
Plasmid isolation and curing. The plasmid from IMY017 was isolated with a
Zymoprep II yeast plasmid miniprep kit and amplified in E. coli. Sequencing of
the recovered plasmid, which was designated MB5573* (Table 2), was performed
by BaseClear. Plasmid loss in strain IMY017 was achieved by growth under
nonselective conditions on liquid YPD. After several serial transfers, the culture
was plated on YPD agar. A single colony isolate, which displayed uracil auxot-
rophy and for which plasmid loss was supported by PCR, was named IMW012
(Table 1).
Metabolite analysis. Extracellular concentrations of glucose and ethanol were
determined by high-performance liquid chromatography, using a Bio-Rad
Aminex HPX-87H column eluted with 5 mM H2SO4 at a flow rate of 0.6 ml
min1 and kept at 60°C, coupled to a Waters 2410 refractive index detector.
Preparation of cell extracts. Samples for enzyme activity measurements were
obtained from shake flask cultures on synthetic stock medium, with glucose and
aspartate, or 3% (vol/vol) ethanol as the carbon source(s). Cells, harvested in the
exponential phase before depletion of either glucose or ethanol, were centri-
fuged, washed, and resuspended in potassium phosphate buffer (10 mM [pH 7.5],
with 2 mM EDTA) and stored at 20°C (each sample contained 60 mg
biomass dry weight). Cell extracts for isocitrate lyase, pyruvate decarboxylase,
and phospho-enol-pyruvate carboxykinase were prepared as described earlier
(41). For malic enzyme, cell extracts were prepared in 50 mM Tris-HCl buffer
(pH 7.5) containing 1 mM dithiothreitol and 2 mM MgCl2 and dialyzed against
this buffer for 4 h at 4°C using 3 ml 10K MWCO Slide-A-Lyzer Dialysis Cassettes
(Thermo Scientific).
Enzyme activity assays. Activities of isocitrate lyase, pyruvate decarboxylase
and phospho-enol-pyruvate carboxykinase were determined as previously de-
scribed (9, 11). As similar assay mixtures have been used to determine in vitro
malic enzyme activities for S. cerevisiae and E. coli (4, 5), malic enzyme activities
were determined as described for S. cerevisiae (4) with either 0.4 mM NAD or
NADP as the redox cofactor. Malic enzyme activity was measured in the
decarboxylating direction to avoid interference with pyruvate decarboxylase and
alcohol dehydrogenase. Values for Vmax and Km were determined with nonlinear
fits, assuming Michaelis-Menten kinetics (using GraphPad Prism 4).
RESULTS
Expression of E. coli NAD-dependent malic enzyme is in-
sufficient to rescue C4 auxotrophy of Pyc
 S. cerevisiae. In
wild-type S. cerevisiae grown on glucose, pyruvate carboxylase
functions as the sole anaplerotic enzyme (6, 29), replenishing
the intracellular pools of C4 acids. To test whether malic en-
zyme can assume this anaplerotic role in pyruvate carboxylase-
negative (Pyc) S. cerevisiae, a codon-optimized version of the
E. coli NAD-dependent malic enzyme, sfcA (also known as
maeA), was overexpressed in the pyc1 pyc2 strain IMK157,
resulting in strain IMY019. Compared to the Pyc empty vec-
tor control strain IMY007, overexpression of the E. coli malic
enzyme increased in vitro NAD-dependent malic enzyme ac-
tivity by circa 8-fold to 0.49  0.03 mmol min1 g of protein1
(Table 4). However, strain IMY019 showed no growth on
synthetic medium agar plates with glucose as the sole carbon
source, even when cultures were incubated under a CO2 at-
mosphere to thermodynamically favor pyruvate carboxylation
(Fig. 1).
To test whether increased intracellular substrate concentra-
tions would allow for an anaplerotic flux through malic en-
zyme, an attempt was made to increase intracellular pyruvate
levels by deleting PDC2, which encodes a positive regulator of
the pyruvate decarboxylase (Pdc) isozymes Pdc1 and Pdc5 (16).
Pyruvate decarboxylases convert pyruvate to acetaldehyde, a
crucial step in the formation of ethanol. Deletion of PDC2 has
previously been shown to result in a 3- to 4-fold reduction of
Pdc activity in aerobic glucose-limited chemostat cultures, and
TABLE 3. Oligonucleotides used in this study
Oligonucleotide Sequence (5–3)
5-PDC2-S1 ............................................ACGCAACTTGAATTGGCAAAATGGGCTTATGAGACGTTCCCAGCTGAAGCTTCGTACGC
3-PDC2-S2 ............................................AGCCTGTGTTACCAGGTAAGTGTAAGTTATTAGAGTCTGGGCATAGGCCACTAGTGGATCTG
5-MAE1-XbaI ......................................CGACGGATTCTAGAGGTTATGCTTAGAACCAGACTATCCG
5-sMAE1-XbaI.....................................ACCATCTAGAATGTGGCCTATTCAGCAATCGCG
3-MAE1-SalI ........................................GTTAGTCGACCTACAATTGGTTGGTGTGCACC
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in substantial production of pyruvate during batch cultivation
on glucose (10). In the present study, PDC2 was deleted in
strain IMK157, yielding strain IMK299. Subsequent overex-
pression of the E. coli sfcA malic enzyme in the pyc1,2 pdc2
strain IMK299 resulted in strain IMY016 (Table 1). Although
a 2-fold reduction in pyruvate decarboxylase activity was
observed in cell extracts relative to the parental strain IMY019
(Table 4), strain IMY016 showed no growth on glucose, re-
gardless of whether an air or CO2 atmosphere was applied
(Fig. 1).
Evolutionary engineering for increased anaplerotic flux. To
select for mutants with an increased anaplerotic flux through
malic enzyme, evolutionary engineering was used, a strategy
that previously proved successful for enabling anaplerosis in S.
cerevisiae via PEPCK. After precultivation on glucose and as-
partate, strain IMY016 was inoculated at an initial OD660 of
circa 0.5 in a CO2-sparged batch bioreactor, containing syn-
thetic medium with glucose as the sole carbon source. After a
week of incubation without growth, aspartate was pulsed to
allow the (viable) biomass concentration to increase. Subse-
quent nitrogen-limited chemostat cultivation on glucose me-
dium at a dilution rate of 0.05 h1 resulted in partial washout,
and feeding was stopped. During the following batch phase,
growth was observed. After two additional washout-batch cy-
cles on medium with glucose as the sole carbon source, a
specific growth rate of 0.06 h1 was reached. At the end of the
TABLE 4. In vitro whole-cell enzyme activities
Strain max (h1)
Mean enzyme activity (mmol min1 g of protein1)  SDa
ME-NAD ME-NADP Pdc PEPCK Icl
CEN.PK 113-7D 0.30  0.01 0.04  0.00 0.03  0.00 1.5  0.2 0.04  0.01 ND
CEN.PK 113-7D on ethanol NA 0.09  0.02 0.02  0.00 0.2  0.0 0.44  0.05 0.22  0.03
IMY007 (pyc1,2, empty vector) NG 0.06  0.00 0.03  0.01 1.9  0.3 0.04  0.00 ND
IMY019 (pyc1,2, E. coli sfcA) NG 0.49  0.03 0.03  0.00 1.6  0.1 0.04  0.00 ND
IMY016 (pyc1,2 pdc2, E. coli sfcA) NG 1.03  0.07 0.03  0.00 0.7  0.0 0.04  0.01 ND
IMY017 (pyc1,2 pdc2 evolved, mutated E. coli sfcA) 0.06  0.01 0.12  0.01 0.39  0.02 0.7  0.0 0.04  0.02 ND
IMY027 (pyc1,2 pdc2, 1MAE1) NG 0.30  0.03 0.34  0.04 0.5  0.0 0.04  0.00 ND
IMY028 (pyc1,2 pdc2, 1sMAE1) 0.012  0.000 0.17  0.01 0.18  0.01 0.7  0.0 0.04  0.00 ND
IMY029 (pyc1,2 pdc2, 1sMAE1), IMY017 background 0.019  0.003 0.18  0.02 0.19  0.02 1.3  0.0 0.04  0.00 ND
a Abbreviations: ME-NAD; malic enzyme (with NAD); ME-NADP, malic enzyme (with NADP); Pdc, pyruvate decarboxylase; PEPCK, phospho-enol-pyruvate
carboxykinase; Icl, isocitrate lyase. Yeast strains were grown on synthetic medium with glucose and aspartate unless indicated otherwise. Errors are deviations from
mean (for each condition two shake flask cultures were run). Also indicated are the maximum specific growth rates (max) on glucose under a CO2 atmosphere in batch
cultures. NA, not applicable; ND, not detectable (	0.005 mmol min1 g of protein1); NG, no growth (tested on plates).
FIG. 1. Synthetic medium agar plates, incubated for 14 days under an atmosphere of either 1.2 bar CO2 (plates A and B) or air (plates C and
D). Plates contained glucose, Tween 80 and ergosterol and, as the nitrogen source, either ammonium sulfate (plates A and C) or aspartate (plates
B and D). Strains: 1, CEN.PK 113-7D (wild-type reference); 2, IMY016 (pyc1,2 pdc2, E. coli sfcA); 3, IMY017 (pyc1,2 pdc2 evolved, mutated
E. coli sfcA); 4, IMY019 (pyc1,2, E. coli sfcA); 5, IMY024 (pyc1,2 pdc2, mutated E. coli sfcA); 6, IMY025 (pyc1,2, 1MAE1); 7, IMY026
(pyc1,2, 1sMAE1); 8, IMY027 (pyc1,2 pdc2, 1MAE1); 9, IMY028 (pyc1,2 pdc2, 1sMAE1); 10, IMY029 (pyc1,2 pdc2 evolved,
1sMAE1). sMAE1 is a truncated, cytosolically retargeted version of S. cerevisiae MAE1.
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bioreactor cultivation a culture sample was taken and incu-
bated on synthetic medium agar with glucose as the sole car-
bon source. Growth on plates was now observed, but only when
plates were incubated under a CO2 atmosphere. This was con-
sistent with an anaplerotic role of malic enzyme and indicated
that growth did not result from cells with a derepressed glyoxy-
late cycle (3), for which CO2 is not a substrate. A single colony
isolate from the evolved culture, designated IMY017 (Fig. 1),
showed a representative maximum specific growth rate of
0.06  0.01 h1 in CO2-sparged batch cultures on glucose. At
a specific growth rate of 0.06 h1, a single gain-of-function
mutant cell would be able to grow to a stationary phase culture
in the 1-liter bioreactor (corresponding to approximately 35
generations) within 2 weeks. This time span is well within the
1-month duration of the selective cultivation.
Reverse engineering: a switch in cofactor specificity of E. coli
malic enzyme. To identify the basis of the changed phenotype,
the in vitro enzyme activities of malic enzyme, pyruvate decar-
boxylase, PEPCK, and isocitrate lyase were determined in cell
extracts of strain IMY017. Consistent with the strong CO2
dependence observed for growth on glucose (Fig. 1), no activ-
ity was found for isocitrate lyase, confirming that the glyoxylate
cycle, which is normally repressed during batch cultivation on
glucose, did not act as an anaplerotic pathway in the evolved
strain. The PEPCK activity remained low at 0.04  0.02 mmol
min1 g of protein1, while no further decrease in Pdc activity
was observed compared to IMY016 (Table 4). However, large
changes were observed for malic enzyme. Whereas NAD-
dependent malic enzyme activity had dropped over 8-fold to
0.12  0.01 mmol min1 g of protein1, NADP-dependent
activity had increased over 10-fold to 0.39  0.02 mmol min1
g of protein1 (Table 4).
The enzyme activity measurements provided strong indica-
tions that the new phenotype was primarily due to changes to
E. coli malic enzyme. Indeed, when the plasmid from IMY017,
named MB5573*, was retransformed to IMK299, the resulting
strain immediately showed growth on glucose under a CO2
atmosphere (strain IMY024, Fig. 1). Growth was slower than
for IMY017, suggesting that additional beneficial mutations
had occurred in IMY017 on a genomic level. No growth was
observed when the original MB5573 plasmid or an empty plas-
mid were retransformed to a cured IMY017, or when the
MB5573* plasmid isolated from IMY017 was transformed to
strain IMK157, which still carried an intact copy of PDC2 (data
not shown).
Subsequent sequencing of the sfcA open reading frame, as
well as its TDH3 promoter and CYC1 terminator, in the
MB5573* strain uncovered a single A1007G point mutation
resulting in an Asp336Gly amino acid change. This mutation
lies in the NAD domain of sfcA and is close to the 311- to
319-amino-acid sequence that is predicted to be the NAD(P)-
binding site (5). Interestingly, sequencing of the plasmid from
an independently evolved single colony isolate, which like
strain IMY017 showed growth on glucose but was not further
investigated due to a low specific growth rate on glucose of
0.02  0.00 h1, uncovered a G1006A point mutation, result-
ing in a change of the same amino acid residue (in this case an
Asp336Asn substitution).
To test whether the A1007G mutation had indeed changed
the cofactor specificity and to avoid interference of the endog-
enous Mae1p in enzyme assays, the original and mutated E.
coli malic enzyme were introduced in a mae1 knockout strain
from the Saccharomyces Genome Deletion Project (37) (Table
1). Although PCR confirmed the deletion of mae1, low back-
ground activities were still found in the malic enzyme assay
for a mae1 deletion strain carrying an empty vector (strain
IMY030). However, at ca. 5% of the activities measured
for the strains carrying MB5573 (IMY031) or MB5573*
(IMY032), this did not significantly influence the character-
ization of the E. coli malic enzyme. Interestingly, the
A1007G point mutation in sfcA resulted in a 2-fold lower
Vmax on NAD
, and a slightly increased Vmax on NADP

(Table 5). However, a far more striking effect was observed
for the cofactor substrate saturation constants. In the mu-
tated E. coli malic enzyme, the Km for NAD
 had decreased
30-fold, while the Km for NADP
 was improved by ap-
proximately the same factor (Table 5). Combined, these
changes effected a drastic switch in cofactor specificity.
An anaplerotic role for cytosolically targeted S. cerevisiae
Mae1p. After having established the importance of cofactor
specificity in the anaplerotic role of the E. coli enzyme, re-
placement of the anaplerotic role of pyruvate carboxylase by
alleles of the native yeast malic enzyme, encoded by MAE1,
was investigated. Interestingly, the endogenous malic enzyme
already has the potential to use NADPH as the cofactor, but is,
in contrast to the heterologously expressed E. coli enzyme,
targeted to the mitochondrion. Therefore, both a full copy of
MAE1 and a truncated version lacking the mitochondrial tar-
geting sequence, named sMAE1 (21), were overexpressed in
Pyc S. cerevisiae. No growth was discernible on synthetic
glucose medium for the Pyc strain IMK157 (over)expressing
MAE1 (strain IMY025) or sMAE1 (IMY026), and for the
pyc1,2 pdc2 strain IMK299 overexpressing MAE1
(IMY027). However, colonies were obtained for the pyc1,2
TABLE 5. Kinetic parameters of the original allele of E. coli sfcA NADH-dependent malic enzyme and of a mutated allele obtained by
adaptive evolution in yeast, with either NAD or NADP as the redox cofactor
Strain
Kinetic enzyme parameters (mean  SD)a
NAD NADP
Vmax (mmol min1 g
of protein1) Km (mM)
Vmax (mmol min1 g
of protein1) Km (mM)
IMY031 (mae1, E. coli sfcA) 1.8  0.2 0.14  0.05 0.6  0.3 8.7  7.3
IMY032 (mae1, mutated E. coli sfcA) 1.0  0.2 3.9  1.9 0.7  0.1 0.23  0.08
a Measurements were performed in whole-cell extracts of S. cerevisiae strains grown on synthetic medium with glucose and aspartate. Ranges indicate 95% confidence
intervals (for each strain, enzyme assays were performed on cell extracts from two independent shake flasks).
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pdc2 strain IMK299 expressing the cytosolic sMAE1
(IMY028, see Fig. 1). This strain showed a maximum specific
growth rate of 0.012  0.000 h1 on glucose in CO2-sparged
batch cultures.
The characterization of the evolved strain IMY017, which
expresses a mutated copy of the E. coli sfcA gene, suggested
that changes in the yeast genetic background, although not
essential for growth, contributed to its improved growth. To
test whether these unidentified genomic changes would also
benefit a strain expressing the truncated S. cerevisiae malic
enzyme, sMAE1 was expressed in IMY017 after its original
plasmid had been cured. Indeed, growth of the resulting strain
IMY029 was faster on glucose plates (Fig. 1) and in CO2-
sparged batch cultures, where a specific growth rate of 0.019 
0.003 h1 was observed. The relatively low growth rate of this
sMAE1-based strain (the E. coli sfcA-based strain IMY017
showed a maximum specific growth rate of 0.06  0.01 h1)
might in part be explained by a lower NADP-dependent
malic enzyme activity for strain IMY029 compared to strain
IMY017 (0.19  0.02 versus 0.39  0.02 mmol min1 g of
protein1; see Table 4).
DISCUSSION
This study shows that, in addition to a derepressed glyoxylate
cycle (3), heterologous PEP carboxylase (12), and PEPCK
(40), malic enzyme can assume the anaplerotic role in S. cer-
evisiae during growth on glucose that is normally fulfilled by
pyruvate carboxylase (6, 29). This is substantiated by the fact
that isocitrate lyase activity in the Pyc strains remained below
the detection level, growth depended on high CO2 levels,
which would only benefit anaplerotic routes involving carbon
fixation, and, also in the evolved strains, growth required the
overexpression of (cytosolic) malic enzyme. A significant car-
boxylating flux through PEPCK is not expected, since PEPCK
activities were not increased after evolution, and in vitro en-
zyme activities were only a fraction of those found in PEPCK-
anaplerotic strains (0.04 versus 0.29 to 0.87 mmol min1 g of
protein1; see reference 40). Similarly, the low expression lev-
els of endogenous MAE1 and mitochondrial localization of
Mae1p make it unlikely that malic enzyme made a significant
contribution to the anaplerotic flux in the earlier-characterized
PEPCK-expressing S. cerevisiae strains (40). The present study
has shown that a cytosolic localization is crucial for enabling an
anaplerotic role of malic enzyme, which might be explained by
less favorable conditions for carboxylation in the mitochon-
drial matrix, an inability to generate mitochondrial NAD(P)H,
and/or limitations in the transport of C4 acids from the mito-
chondria to the cytosol.
NADPH as a preferred cofactor. The NAD-specific E. coli
sfcA malic enzyme was chosen based on several grounds: (i) as
a prokaryotic protein, sfcA lacks an intracellular targeting se-
quence, and thus can be expected to be cytosolically expressed
in S. cerevisiae; (ii) previous studies on malic enzyme as a
carboxylating enzyme in E. coli also targeted sfcA (17, 27); and
(iii) if malic enzyme would be used for the high-yield produc-
tion of C4-dicarboxylic acids, the use of NADH instead of
NADPH would simplify the balancing of cofactors (e.g., avoid-
ing the need for transhydrogenase activity for the production
of malate and fumarate, which can be produced redox neu-
trally from glucose). However, the Pyc S. cerevisiae only grew
when expressing either the cytosolically relocalized sMAE1p,
which can use both NADH and NADPH, or a mutated sfcA
allele with a strongly improved affinity for NADPH. This indi-
cates that, in the tested strains, anaplerosis via malic enzyme
depended on the use of NADPH for reductive pyruvate car-
boxylation.
The Asp336Gly mutation clearly resulted in a near complete
switch of the cofactor specificity from NAD to NADP in E.
coli malic enzyme. This preferential use of NADPH by malic
enzyme in this carboxylating role might be explained by the
thermodynamics of the catalyzed reaction. The dependency of
growth on deletion of PDC2, which probably increased the
cytosolic pyruvate concentration, and on incubation under a
CO2 atmosphere, both indicate that this reaction is likely to be
close to thermodynamic equilibrium when operating in the
carboxylating direction. Although few measurements are avail-
able on cytosolic redox factor concentrations in S. cerevisiae
(8), whole-cell measurements showed intracellular ratios of
NADPH/NADP that are higher than those of NADH/NAD
(21). If this is representative for the cofactor distribution in the
cytosol, the use of NADPH would increase the driving force of
carboxylation by cytosolic malic enzyme.
Malic enzyme for C4 acid production by S. cerevisiae. Like
PEPCK, malic enzyme offers the prospect of metabolic engi-
neering of S. cerevisiae for C4-dicarboxylic acid production
from glucose under anaerobic conditions (40). The higher ATP
yield of carboxylation might eliminate the need to respire part
of the glucose for ATP generation, thereby increasing product
yields. In view of the relatively low growth rates of the current
strains (0.06 h1 with the mutated E. coli malic enzyme versus
0.14 h1 for PEPCK-anaplerotic strains and 0.30 h1 for the
pyruvate carboxylase-positive reference strain [40]), the first
priority will be to increase the in vivo rates of pyruvate carbox-
ylation by malic enzyme. Initially, sequential batch cultivation
can be used to select for faster growth and a higher anaplerotic
flux. Further increases in the carboxylating fluxes through
malic enzyme or PEPCK might be achieved by improving sub-
strate availability and reducing the flux to ethanol. Such an
approach previously proved successful in engineering a pyru-
vate carboxylase-overexpressing S. cerevisiae strain, which was
unable to produce ethanol due to deletion of the pyruvate
decarboxylase genes, for malate and succinate production (38,
39). The increased availability of pyruvate in pyruvate decar-
boxylase-negative strains can also improve the carboxylation
through malic enzyme. As an additional benefit, when ATP
generation becomes dependent on the production (and export)
of C4-dicarboxylic acids, this might allow for evolutionary en-
gineering for an improved flux through malic enzyme (40).
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